Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.8 USD | +3.32% | +0.72% | +12.00% |
May. 02 | Transcript : Arbutus Biopharma Corporation, Q1 2024 Earnings Call, May 02, 2024 | |
May. 02 | Earnings Flash (ABUS) ARBUTUS BIOPHARMA CORPORATION Posts Q1 Revenue $1.5M | MT |
Sales 2024 * | 9.04M 6.61M | Sales 2025 * | 8.08M 5.91M | Capitalization | 722M 528M |
---|---|---|---|---|---|
Net income 2024 * | -98M -71.62M | Net income 2025 * | -102M -74.55M | EV / Sales 2024 * | 79.9 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 89.3 x |
P/E ratio 2024 * |
-7.16
x | P/E ratio 2025 * |
-7.12
x | Employees | 73 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 77.71% |
Latest transcript on Arbutus Biopharma Corporation
1 day | +3.32% | ||
1 week | +0.72% | ||
Current month | +2.56% | ||
1 month | -10.26% | ||
3 months | +13.36% | ||
6 months | +48.94% | ||
Current year | +12.00% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 50 | 14-06-30 | |
David Hastings
DFI | Director of Finance/CFO | 62 | 18-06-10 |
Karen Sims
CTO | Chief Tech/Sci/R&D Officer | 53 | 17-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 14-11-30 | |
James Meyers
BRD | Director/Board Member | 59 | 18-10-22 |
Daniel Burgess
BRD | Director/Board Member | 62 | 17-03-22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.03% | 0 M€ | 0.00% | - | |
0.03% | 2 M€ | -.--% | ||
0.02% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 2.8 | +3.32% | 685,435 |
24-05-03 | 2.71 | +1.12% | 683,613 |
24-05-02 | 2.68 | -0.37% | 673,239 |
24-05-01 | 2.69 | -1.47% | 1,028,210 |
24-04-30 | 2.73 | -1.80% | 1,011,387 |
Delayed Quote Nasdaq, May 06, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.00% | 528M | |
-2.47% | 88.14B | |
+1.45% | 40.44B | |
-14.43% | 32.24B | |
+53.11% | 24.39B | |
-14.85% | 15.59B | |
-13.87% | 12.14B | |
-7.87% | 12.18B | |
-39.40% | 12.3B | |
+5.24% | 8.87B |
- Stock Market
- Equities
- ABUS Stock